For these cancer trials, participants typically need insurance to cover all the non-experimental components
Editor information Editors and Affiliations Rights and permissions Copyright information 2011 Springer Science+Business Media, LLC About this protocol Cite this protocol Harper, S., Speicher, D.W
Studies show that female SESN2 KO mice exhibit exacerbated glucose intolerance and hepatosteatosis, while its overexpression or exercise-induced upregulation mitigates these metabolic disturbances [40, 41]
CJC-1295 does not directly stimulate testosterone production
Beyond Barriers is confident the results will be more robust when delivered intranasally. Using a repurposed drug lets the company pursue the 505(b)(2) FDA approval pathway, which Kole says, has a three-fold better chance of success of approval than the traditional 505(b)(1) route and is less expensive and time-intensive. Administration doses and schedules are to be determined, but early research suggests the administration window may be as long as 72 hours after injury
These findings suggest that loganin may be an effective adjuvant in cisplatin-based cancer therapies
